Skip to content

Home
About
Investment Strategy
Portfolio
News
Contact

Zymergen Series C

December 13, 2018

Zymergen lands $400 million more for its genetically-altered microbes led by Softbank Vision Fund

Investing in exceptional founders building the future.

Home
About
Portfolio
News
Contact

© 2026 AgileAngel. All rights reserved.